Viewing nowUniLansop Capsule 30 mg (Lansoprazole)
Lansoprazole Granules 353mg
Hard capsule · Prescription medication
Unimed Pharmaceutical Co., Ltd.

MFDS item code 200403814 · Notified 2004.09.22 · Insurance code 649502140
Treatment and prevention of gastric and duodenal ulcers and eradication therapy; treatment of gastroesophageal reflux; suppression of excessive gastric acid secretion
This medication is used for the short-term treatment of active duodenal ulcers and benign gastric ulcers. It also aids the eradication of Helicobacter pylori to prevent the recurrence of duodenal ulcers and is effective in the maintenance therapy after ulcer treatment. It is also used for treating gastric ulcers induced by non-steroidal anti-inflammatory drugs and reducing the risk of occurrence. Applicable for short-term treatment of gastroesophageal reflux disease and erosive esophagitis, as well as assisting in the treatment of pathological hypersecretion states like Zollinger-Ellison syndrome. Overall, it is used to treat conditions related to gastric and duodenal ulcers and gastroesophageal reflux disease, as well as disorders associated with excessive gastric acid secretion.
This medicine should be taken before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange or tomato juice, and administer immediately. To ensure the full dose is taken, rinse the glass with twice the amount of juice or more and drink immediately. After opening the capsule, do not chew or crush the contents before taking them. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer: Administer lansoprazole 30 mg with clarithromycin 250–500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if needed. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer: Administer lansoprazole 30 mg with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. Comparative clinical trials did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Comparative clinical trials did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. Comparative clinical trials did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome: Lansoprazole dosing for pathological hypersecretory conditions varies by patient. Treatment in adults is usually initiated at 60 mg once daily. Adjust the dose according to the patient's needs and continue for as long as it is clinically effective. Doses of 90 mg twice daily have been used. If the daily dose exceeds 120 mg, administer it in divided doses. Because clearance of this medicine is reduced in older adults, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. Use with caution, including dose adjustment, in patients with hepatic impairment because metabolism and excretion of this medicine may be delayed.
Children and adolescents aged 12–17 years, short-term treatment of symptoms associated with nonerosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12–17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1–11 years, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1–11 years, over 30 kg: 30 mg once daily for 12 weeks
This medication should not be used by patients with allergies to specific ingredients or those who have experienced hypersensitivity reactions. Particularly, it should not be administered to pregnant women or individuals with certain genetic lactose intolerance. Caution is advised for those with poor liver function, elderly patients, children, and nursing women when using this medication. If severe allergic reactions, skin rashes, or breathing difficulties occur while taking this medication, usage should be immediately stopped and a doctor consulted. Regular testing is needed as problems with the liver or kidneys may arise, and any abnormal symptoms should be reported promptly. Symptoms such as diarrhea, abdominal pain, and headaches may occur, so appropriate measures should be taken based on symptoms. Long-term use may lead to vitamin B12 deficiency or hypomagnesemia, so regular blood tests are recommended. This medication can interact with other drugs, so if taking any other medications, inform your doctor or pharmacist. Caution is especially needed when used with antibiotics, anticoagulants, immunosuppressants, and certain heart medications. It is safest to avoid using this medication during pregnancy or nursing, and if it must be used, follow the directions of a healthcare professional. Dizziness or drowsiness may occur, so caution should be exercised when driving or operating machinery. In case of overdose, seek medical attention immediately as this medication is not removed by hemodialysis. Keep this medication out of reach of children and do not transfer it to another container. If gastrointestinal bleeding or severe digestive symptoms occur while taking this medication, consult a doctor immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 degrees and 30 degrees Celsius.
A hard capsule filled with white to light brown granules.
28 capsules per bottle, 30 capsules per bottle, 90 capsules per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLansoprazole Granules 353mg
Hard capsule · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Lansoprazole Granules 370mg
Hard capsule · Prescription medication
Cheil Pharmaceutical Co., Ltd.

Lansoprazole Granules 353mg
Hard capsule · Prescription medication
International Pharmaceutical Co., Ltd.

Lansoprazole Granules 185mg
Hard capsule · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Lansoprazole Granules 353mg
Hard capsule · Prescription medication
PharmGen Science Co., Ltd.

Lansoprazole Granules 176.5mg
Hard capsule · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Lansoprazole Granules 176.5mg
Hard capsule · Prescription medication
Korea PMG Pharmaceuticals Co., Ltd.

Lansoprazole Granules 353mg
Hard capsule · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.